Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Head and Neck Cancer

  Free Subscription


1 BMC Cancer
2 Br J Cancer
1 Br J Ophthalmol
2 Clin Cancer Res
1 J Clin Oncol
2 Oral Oncol
1 Thyroid

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Cancer

  1. YU J, Ouyang W, Li C, Shen J, et al
    Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition.
    BMC Cancer. 2019;19:927.
    PubMed     Text format     Abstract available

    Br J Cancer

  2. GILBERT DC, Wakeham K, Langley RE, Vale CL, et al
    Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
    Br J Cancer. 2018 Nov 28. pii: 10.1038/s41416-018-0273.
    PubMed     Text format     Abstract available

  3. NICHOLLS JM, Lee VH, Chan SK, Tsang KC, et al
    Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
    Br J Cancer. 2019 Sep 17. pii: 10.1038/s41416-019-0575.
    PubMed     Text format     Abstract available

    Br J Ophthalmol

  4. LEE GI, Kim YD, Young SM, Shin S, et al
    Clinical characteristics and treatment outcomes of natural killer/T-cell lymphoma involving the ocular adnexa.
    Br J Ophthalmol. 2018 Apr 29. pii: bjophthalmol-2017-311704.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  5. QIN Y, Wu CW, Taylor W, Sawas T, et al
    Discovery, validation, and application of novel methylated DNA markers for detection of esophageal cancer in plasma.
    Clin Cancer Res. 2019 Sep 16. pii: 1078-0432.CCR-19-0740.
    PubMed     Text format     Abstract available

  6. VENTZ S, Trippa L, Schoenfeld JD
    Lessons Learned from De-escalation trials in favorable risk HPV-associated Squamous Cell Head and Neck Cancer - A Perspective on future trial designs.
    Clin Cancer Res. 2019 Sep 16. pii: 1078-0432.CCR-19-0945.
    PubMed     Text format     Abstract available

    J Clin Oncol

  7. PATIL VM, Noronha V, Joshi A, Dhumal S, et al
    Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.
    J Clin Oncol. 2019 Sep 20:JCO1901076. doi: 10.1200/JCO.19.01076.
    PubMed     Text format     Abstract available

    Oral Oncol

  8. DE MARCHI P, Melendez ME, Laus AC, Kuhlmann PA, et al
    The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer.
    Oral Oncol. 2019;98:48-52.
    PubMed     Text format     Abstract available

  9. DIONISI F, Fiorica F, D'Angelo E, Maddalo M, et al
    Organs at risk's tolerance and dose limits for head and neck cancer re-irradiation: A literature review.
    Oral Oncol. 2019;98:35-47.
    PubMed     Text format     Abstract available


  10. KOHLER H, Latteyer S, Hoenes S, Theurer S, et al
    Increased ALK activity induces a poorly differentiated thyroid carcinoma in mice.
    Thyroid. 2019 Sep 16. doi: 10.1089/thy.2018.0526.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.